Terms: = Leukemia AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Diagnosis
3871 results:
1. Association of serum protein electrophoresis with clinicopathological characteristics and its prognostic relevance in chronic lymphocytic leukaemia patients.
Hameed A; Sajid N; Javaid RB; Ali N
J Pak Med Assoc; 2024 Apr; 74(4):711-718. PubMed ID: 38751267
[TBL] [Abstract] [Full Text] [Related]
2. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Heim D; Baldomero H; Medinger M; Masouridi-Levrat S; Schanz U; Nair G; Güngör T; Halter J; Passweg JR; Chalandon Y;
Swiss Med Wkly; 2024 May; 154():3754. PubMed ID: 38749067
[TBL] [Abstract] [Full Text] [Related]
3. Clinical Characteristics and diagnosis of Ph-Positive Mixed Phenotype Acute leukemia.
Zhang X; Li R; Zhang X; Li J; Li X; Chen J; Li H
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747916
[TBL] [Abstract] [Full Text] [Related]
4. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
[TBL] [Abstract] [Full Text] [Related]
5. Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later.
Max RN; Daniela SB; Moisés M GP; Edgar J HF; Merittzel A MR; María de L PM; Juan C OG; Guillermo J RD; Guillermo J RA
Rev Invest Clin; 2024; 76(2):91-96. PubMed ID: 38740380
[TBL] [Abstract] [Full Text] [Related]
6. Hopelessness and Social Support among Cancer Patients in Saudi Arabia.
Rawas H; De Beer J; Alturki O; Altorki M; Alhelali T; Althagfi A; Faisal N; Albalawi F; Khan MA
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1363-1370. PubMed ID: 38679998
[TBL] [Abstract] [Full Text] [Related]
7. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
[TBL] [Abstract] [Full Text] [Related]
8. [Gene Profile and Clinical Significance of Concomitant Mutations in CN-AML Patients with
Zhu J; Kang YF; Gao Y; Wang HW; Hao ZH; Wang HW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):335-341. PubMed ID: 38660833
[TBL] [Abstract] [Full Text] [Related]
9. Gene expression profiling of vitamin D metabolism enzymes in leukemia and lymphoma patients: molecular aspect interplay of VDR, CYP2R1, and CYP24A1.
Iriani A; Rachman A; Fatina MK; Gemilang RK; Trisnandi A; Nugraha MFI
Mol Biol Rep; 2024 Apr; 51(1):526. PubMed ID: 38632160
[TBL] [Abstract] [Full Text] [Related]
10. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
[TBL] [Abstract] [Full Text] [Related]
11. A case of pancreatic PEComa with prominent inflammatory cell infiltration: the inflammatory subtype is a distinct histologic group of PEComa.
Tsukita H; Koyama K; Ishinari T; Takahashi A; Miyabe K; Umakoshi M; Yoshida M; Kudo-Asabe Y; Nishida A; Otsuka N; Yasui O; Kato I; Fukushima N; Goto A
Diagn Pathol; 2024 Apr; 19(1):59. PubMed ID: 38622713
[TBL] [Abstract] [Full Text] [Related]
12. Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid leukemia Cells.
Tezcanli Kaymaz B; Gumus N; Celik B; Alcitepe İ; Biray Avci C; Aktan C
J Interferon Cytokine Res; 2024 Apr; 44(4):178-189. PubMed ID: 38579140
[TBL] [Abstract] [Full Text] [Related]
13. [Discontinuation of tyrosine kinase inhibitors before epiphyseal closure leading to improved short stature in pediatric chronic myelogenous leukemia].
Fukui W; Ogura T; Azumi S; Ogata H; Kawaguchi K; Takachi T; Horikoshi Y; Uematsu A; Shimada H; Watanabe K
Rinsho Ketsueki; 2024; 65(3):175-179. PubMed ID: 38569862
[TBL] [Abstract] [Full Text] [Related]
14. Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial.
Bazinet A; Kantarjian H; Bataller A; Pemmaraju N; Borthakur G; Chien K; Alvarado Y; Bose P; Jabbour E; Yilmaz M; DiNardo C; Issa G; Montalban-Bravo G; Short N; Sasaki K; Bull-Linderman D; Daver N; Garcia-Manero G; Ravandi F; Kadia T
Lancet Haematol; 2024 Apr; 11(4):e287-e298. PubMed ID: 38548404
[TBL] [Abstract] [Full Text] [Related]
15. Short-term chemotherapy-related complications and undernutrition in children diagnosed with cancer at Korle Bu Teaching Hospital, Accra, Ghana: A prospective cohort study.
Salifu N; Segbefia CI; Alhassan Y; Renner LA; Tette EMA
PLoS One; 2024; 19(3):e0301208. PubMed ID: 38547211
[TBL] [Abstract] [Full Text] [Related]
16. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
[TBL] [Abstract] [Full Text] [Related]
17. The Screening of microRNAs in Chronic Myeloid leukemia: A Clinical Evaluation.
Wosniaki DK; Marin AM; Oliveira RN; Koerich GM; Munhoz EC; Farias JSH; Beltrame MP; Zanette DL; Aoki MN
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542337
[TBL] [Abstract] [Full Text] [Related]
18. Acute Lymphoblastic leukemia With Near-haploid Karyotype and Philadelphia Chromosome.
Panagopoulos I; Andersen K; Wik HS; Tandsæther MR
Anticancer Res; 2024 Apr; 44(4):1389-1397. PubMed ID: 38537997
[TBL] [Abstract] [Full Text] [Related]
19. Exclusive Breastfeeding Duration and Risk of Childhood Cancers.
Søegaard SH; Andersen MM; Rostgaard K; Davidsson OB; Olsen SF; Schmiegelow K; Hjalgrim H
JAMA Netw Open; 2024 Mar; 7(3):e243115. PubMed ID: 38530315
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of childhood malignancies presenting with musculoskeletal manifestations from two different divisions: a multicenter study.
Çağlayan Ş; Koç BŞ; Baba Ö; Bağlan E; Kurucu B; Yıldırım DG; Ayhan AC; Çakan M; Yener GO; Öztürk K; Çakmak F; Sönmez HE; Ayaz NA; Kısaarslan AP; Bakkaloğlu S; Kalyoncu M; Kılıç SÇ; Sözeri B
Turk J Pediatr; 2024; 66(1):81-89. PubMed ID: 38523382
[TBL] [Abstract] [Full Text] [Related]
[Next]
